---
title: "納百川新能源為其 IPO 定價，計劃募集最多 6.32 億元人民幣"
description: "納百川新能源價格首次公開募股，尋求最高 6.32 億元的募資"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/268682053.md"
published_at: "2025-12-05T00:35:41.000Z"
---

# 納百川新能源為其 IPO 定價，計劃募集最多 6.32 億元人民幣

> 納百川新能源價格首次公開募股，尋求最高 6.32 億元的募資

### Related Stocks

- [301667.CN - 納百川](https://longbridge.com/zh-HK/quote/301667.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Averin Capital Acquisition Closes IPO | Averin Capital Acquisition Closes IPO | [Link](https://longbridge.com/zh-HK/news/276488533.md) |
| iFOREX Announces Successful Pricing Of Its IPO At 195 Pence Per Ordinary Share | IFOREX FINANCIAL : IFOREX FINANCIAL - PROSPECTUS AND ANNOUNCEMENT OF OFFER PRICEIFOREX: ANNOUNCES SUCCESSFUL PRICING OF  | [Link](https://longbridge.com/zh-HK/news/276345476.md) |
| Liftoff announces confidential submission of draft registration statement for proposed IPO | Liftoff announces confidential submission of draft registration statement for proposed IPO | [Link](https://longbridge.com/zh-HK/news/276180047.md) |
| Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering \| ACAAU Stock News | Averin Capital Acquisition Corp. has priced its initial public offering at $250 million, offering 25 million units at $1 | [Link](https://longbridge.com/zh-HK/news/276276275.md) |
| Synthetic regenerative graft developer Medical 21 files for a $25 million IPO | Medical 21, a Minneapolis-based developer of synthetic regenerative grafts for CABG surgery, has filed with the SEC for  | [Link](https://longbridge.com/zh-HK/news/276343434.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。